Global Health Limited (MEDANTA) - Net Assets

Latest as of March 2026: Rs39.84 Billion INR ≈ $430.88 Million USD

Based on the latest financial reports, Global Health Limited (MEDANTA) has net assets worth Rs39.84 Billion INR (≈ $430.88 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs59.05 Billion ≈ $638.60 Million USD) and total liabilities (Rs19.21 Billion ≈ $207.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible net worth ratio of Global Health Limited to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs39.84 Billion
% of Total Assets	67.47%
Annual Growth Rate	15.98%
5-Year Change	146.55%
10-Year Change	N/A
Growth Volatility	14.26

Global Health Limited - Net Assets Trend (2018–2026)

This chart illustrates how Global Health Limited's net assets have evolved over time, based on quarterly financial data. See MEDANTA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Global Health Limited (2018–2026)

The table below shows the annual net assets of Global Health Limited from 2018 to 2026. For live valuation and market cap data, see MEDANTA market cap overview.

Year	Net Assets	Change
2026-03-31	Rs39.84 Billion ≈ $430.88 Million	+17.62%
2025-03-31	Rs33.88 Billion ≈ $366.35 Million	+16.59%
2024-03-31	Rs29.06 Billion ≈ $314.23 Million	+19.66%
2023-03-31	Rs24.28 Billion ≈ $262.60 Million	+50.26%
2022-03-31	Rs16.16 Billion ≈ $174.77 Million	+16.90%
2021-03-31	Rs13.82 Billion ≈ $149.50 Million	+2.43%
2020-03-31	Rs13.50 Billion ≈ $145.95 Million	+1.40%
2019-03-31	Rs13.31 Billion ≈ $143.93 Million	+9.34%
2018-03-31	Rs12.17 Billion ≈ $131.64 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Global Health Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs537.38 Million	1.36%
Other Components	Rs39.08 Billion	98.64%
Total Equity	Rs39.62 Billion	100.00%

Global Health Limited Competitors by Market Cap

The table below lists competitors of Global Health Limited ranked by their market capitalization.

Company	Market Cap
Hanmi Pharm Co Ltd KO:128940	$3.66 Billion
CleanSpark Inc NASDAQ:CLSK	$3.66 Billion
Edgewise Therapeutics Inc NASDAQ:EWTX	$3.66 Billion
Monday.Com Ltd NASDAQ:MNDY	$3.66 Billion
ENAGAS A.A. ADR1/2/EO150 F:EG40	$3.66 Billion
Merit Medical Systems Inc NASDAQ:MMSI	$3.66 Billion
Bullish NYSE:BLSH	$3.65 Billion
CGN Power Co Ltd F:94C	$3.65 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Global Health Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 33,864,100,000 to 39,615,700,000, a change of 5,751,600,000 (17.0%).
Net income of 5,564,600,000 contributed positively to equity growth.
Dividend payments of 134,400,000 reduced retained earnings.
Share repurchases of 98,240,000 reduced equity.
New share issuances of 240,210,000 increased equity.
Other comprehensive income decreased equity by 121,790,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs5.56 Billion	+14.05%
Dividends Paid	Rs134.40 Million	-0.34%
Share Repurchases	Rs98.24 Million	-0.25%
Share Issuances	Rs240.21 Million	+0.61%
Other Comprehensive Income	Rs-121.79 Million	-0.31%
Other Changes	Rs301.22 Million	+0.76%
Total Change	Rs-	16.98%

Book Value vs Market Value Analysis

This analysis compares Global Health Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 8.55x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 26.06x to 8.55x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2018-03-31	Rs48.28	Rs1258.20	x
2019-03-31	Rs51.50	Rs1258.20	x
2020-03-31	Rs53.65	Rs1258.20	x
2021-03-31	Rs54.84	Rs1258.20	x
2022-03-31	Rs64.03	Rs1258.20	x
2023-03-31	Rs93.59	Rs1258.20	x
2024-03-31	Rs108.17	Rs1258.20	x
2025-03-31	Rs126.05	Rs1258.20	x
2026-03-31	Rs147.08	Rs1258.20	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Global Health Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 14.05%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 12.62%
• Asset Turnover: 0.75x
• Equity Multiplier: 1.49x
Recent ROE (14.05%) is above the historical average (9.08%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2018	2.70%	2.40%	0.69x	1.63x	Rs-888.49 Million
2019	3.96%	3.56%	0.58x	1.91x	Rs-782.47 Million
2020	2.69%	2.45%	0.56x	1.98x	Rs-986.27 Million
2021	2.08%	2.02%	0.53x	1.95x	Rs-1.09 Billion
2022	12.14%	9.05%	0.69x	1.95x	Rs345.97 Million
2023	13.43%	12.15%	0.65x	1.70x	Rs832.58 Million
2024	16.46%	14.75%	0.75x	1.48x	Rs1.88 Billion
2025	14.22%	13.24%	0.76x	1.41x	Rs1.43 Billion
2026	14.05%	12.62%	0.75x	1.49x	Rs1.60 Billion

Industry Comparison

This section compares Global Health Limited's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $9,498,811,388
Average return on equity (ROE) among peers: 3.10%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Global Health Limited (MEDANTA)	Rs39.84 Billion	2.70%	0.48x	$3.66 Billion
Apollo Hospitals Enterprise Limited (APOLLOHOSP)	$13.33 Billion	6.41%	0.69x	$13.08 Billion
Aster DM Healthcare Limited (ASTERDM)	$38.34 Billion	3.85%	2.04x	$4.41 Billion
GPT Healthcare Ltd (GPTHEALTH)	$1.01 Billion	7.52%	1.28x	$130.23 Million
Healthcare Global Enterprises Limited (HCG)	$14.10 Billion	0.98%	1.78x	$992.60 Million
Jupiter Life Line Hospitals Limited (JLHL)	$2.88 Billion	17.73%	2.15x	$951.57 Million
Krishna Institute of Medical Sciences Limited (KIMS)	$-1.38 Billion	0.00%	0.00x	$3.42 Billion
Lotus Eye Hospital and Institute Limited (LOTUSEYE)	$493.84 Million	-4.01%	0.14x	$29.88 Million
Max Healthcare Institute Limited (MAXHEALTH)	$10.34 Billion	-2.01%	2.21x	$11.48 Billion
Max India Limited (MAXIND)	$6.37 Billion	-2.53%	0.34x	$95.81 Million

About Global Health Limited

NSE:MEDANTA India Medical Care Facilities

Market Cap

$3.66 Billion

Rs338.10 Billion INR

Market Cap Rank

#4421 Global

#190 in India

Share Price

Rs1258.20

Change (1 day)

+0.30%

52-Week Range

Rs961.10 - Rs1427.20

All Time High

Rs1487.05